Pramlintide approval date?

When was pramlintide approved by the FDA?

Pramlintide (brand name Symlin) was approved by the U.S. Food and Drug Administration on March 16, 2005 [1].

What is pramlintide used for?

Pramlintide is used to improve glycemic control in people with diabetes. The FDA approval date above refers to the initial regulatory action for pramlintide (Symlin) [1].

Where can I verify the approval date?

DrugPatentWatch.com lists FDA approval information for pramlintide (Symlin), including the approval date March 16, 2005 [1].

Sources:
[1] https://www.drugpatentwatch.com/p/drug/pramlintide/